Invention Grant
- Patent Title: Polynucleotide amplification using CRISPR-Cas systems
-
Application No.: US15524962Application Date: 2015-11-10
-
Publication No.: US10577649B2Publication Date: 2020-03-03
- Inventor: Jeffrey G. Mandell
- Applicant: Illumina, Inc.
- Applicant Address: US CA San Diego
- Assignee: Illumina, Inc.
- Current Assignee: Illumina, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2015/059959 WO 20151110
- International Announcement: WO2016/077350 WO 20160519
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12N15/10 ; C12N15/63 ; C12N15/90 ; C12Q1/6853

Abstract:
A method for amplifying a target nucleic acid including providing a system having a crRNA or a derivative thereof, and a Cas protein or a variant thereof. The crRNA or the derivative thereof contains a target-specific nucleotide region substantially complementary to a region of the target nucleic acid, and contacting the target nucleic acid with the system to form a complex.
Public/Granted literature
- US20170342474A1 POLYNUCLEOTIDE AMPLIFICATION USING CRISPR-CAS SYSTEMS Public/Granted day:2017-11-30
Information query